Although OPN has not been directly established as a therapeutic target in AD, its inhibition has demonstrated promising outcomes in other conditions, such as breast and colorectal cancers, where it has led to tumor suppression [49, 50]. This evidence concerns the gene SPP1 and Alzheimer disease.